Concepedia

Pedro Oyuela

PO

7

Publications

1.5K

Citations

7

H-Index

2011

Active since

Affiliations

University of Cambridge(Current)

Associates in Neurology

Cleveland Clinic

McGill University

Brigham and Women's Hospital

Pedro Oyuela is an author at University of Cambridge specializing in multiple sclerosis, medicine, and nephrology.

Top concepts

Publications per year

2011–2015

7

Publications

7

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Cary Twyman, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations · Full text

, , +4

Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis

Gilbert H. Daniels, Anton Vladić, Vesna Brinar et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 146 citations

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

Adam Cuker, Alasdair Coles, H. R. Sullivan et al. · Blood · 2011 · 105 citations · Full text

Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis (CARE-MS) Program

Christina Caon, Marie Namey, Cathy Meyer et al. · International Journal of MS Care · 2015 · 47 citations · Full text

Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing–remitting multiple sclerosis

David Meyer, Alasdair Coles, Pedro Oyuela et al. · Multiple Sclerosis and Related Disorders · 2012 · 39 citations

, , +8

Rows per page

1–5 of 7